AIM AIM ImmunoTech Inc
Company Analysis
Latest News
🔴 AIM ImmunoTech Inc is trading 13.3% down today as profit-taking extends a pullback from its recent trial-driven surge
AIM ImmunoTech Inc is trading 13.3% down at $0.72 in pre-market, extending a sharp pullback from its recent speculative surge. • The stock more than doubled...
🔴 AIM ImmunoTech Inc is trading 7.2% down today as profit-taking continues after pancreatic cancer trial rally
AIM ImmunoTech Inc is trading at $0.77 (7.2% down) in after-hours trading as the stock enters a sharp giveback phase following a recent speculative surge. •...
AIM ImmunoTech Soars Then Stumbles on Pancreatic Cancer Trial News — Can a 20-Employee Biotech Survive the Road to Phase 3?
Shares of AIM ImmunoTech whipsawed this week, surging more than 120% on June 1 before pulling back 13.4% to $0.78 the next day, as traders locked in gains from...
🔴 AIM ImmunoTech Inc is trading 13.4% down today as shares pull back following a sharp rally on trial enrollment news
AIM ImmunoTech Inc is trading at $0.78 (13.4% down) as the stock experiences a pullback following a significant two-day surge tied to its pancreatic cancer...
🟢 AIM ImmunoTech Inc is trading 33.3% up today after announcing early completion of enrollment for its Phase 2 pancreatic cancer trial
AIM ImmunoTech Inc is trading at $0.54 (33.3% up) after announcing a significant milestone in its pancreatic cancer program. • The company announced it has...
🟢 AIM is trading 9.8% up today as volatile rebound continues in thinly traded name
AIM is trading at $0.45 (+9.8%) in pre-market as the stock continues a volatile rebound following recent pressure. • The move appears driven by short-term...
🔴 AIM is trading 10.96% down today on profit-taking after a sharp two-day rebound
AIM is trading 10.96% down at $0.39 on short-term profit-taking following a significant two-day rally. • The pullback follows a rapid move from approximately...
🔴 AIM is trading 10.4% down today on potential profit-taking after a sharp two-day rebound
AIM is trading at $0.39 (10.4% down) today as the stock faces potential profit-taking following a sharp two-day rebound earlier in the week. * No fresh...